Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

被引：0
|
作者：
Nakamura, Minoru
Kondo, Hisayoshi
Mori, Tsuyoshi
Komori, Atsumasa
Matsuyama, Mutsumi
Ito, Masahiro
Daikoku, Manabu
Yatsuhashi, Hiroshi
Takezaki, Eiichi
Masaki, Naohiko
Sugi, Kazuhiro
Adachi, Hiroshi
Sakai, Norihiro
Watanabe, Yukio
Saoshiro, Takeo
Honda, Koichi
Harada, Hideharu
Hayashi, Shigeki
Sando, Takehiro
Masumoto, Akihide
Shimada, Masaaki
Komatsu, Tatsuji
Shums, Zakera
Norman, Gary L.
Ishibashi, Hiromi
机构：
[1] Natl NHO Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Omura, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan
[4] NHO Study Grp Liver Dis Japan, Omura, Japan
[5] INOVA Diagnost, San Diego, CA USA
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1180
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 50 条
  • [21] Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases
    Nagata, Takahiro
    Takeyama, Yasuaki
    Shakado, Satoshi
    Hirai, Fumihito
    Nimura, Satoshi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [22] POSITIVE ANTI-GP210 ANTIBODIES IS A SIGNIFICANT RISK FACTOR FOR BILE DUCT LOSS, HEPATITIS AND POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT THAT LEAD TO MORE SEVERE PROGRESSION IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Nakamura, Minoru
    Ito, Masahiro
    Kondo, Hisayoshi
    Yamamoto, Kazuhide
    Ohira, Hiromasa
    Zeniya, Mikio
    Tanaka, Atsushi
    Hashimoto, Etsuko
    Honda, Masao
    Kaneko, Shuichi
    Ueno, Yoshiyuki
    Kikuchi, Kentaro
    Shimoda, Shinji
    Komori, Atsumasa
    Harada, Kenichi
    Sakisaka, Shotaro
    Takikawa, Hajime
    Onji, Morikazu
    Onishi, Saburo
    Tsubouchi, Hirohito
    Nakanuma, Yasuni
    Ishibashi, Hiromi
    HEPATOLOGY, 2011, 54 : 1208A - 1209A
  • [23] Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis
    Jaskowski, Troy D.
    Nandakumar, Vijayalakshmi
    Novis, Camille L.
    Palmer, Michael
    Tebo, Anne E.
    CLINICA CHIMICA ACTA, 2023, 540
  • [24] Patients with AMA/anti-sp100/anti-gp210 Positivity and Cholestasis Can Manifest Conditions Beyond Primary Biliary Cholangitis
    Zeng, Xin
    Lv, Tingting
    Li, Shuxiang
    Chen, Sha
    Li, Buer
    Lu, Zhijiao
    Wang, Yu
    Ou, Xiaojuan
    Zhao, Xinyan
    You, Hong
    Duan, Weijia
    Jia, Jidong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2025,
  • [25] Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjogren syndrome with subsequent autoimmune hemolytic anemia A case report
    Zhao, Dan-Tong
    Liu, Yan-Min
    Han, Ying
    Zhang, Hai-Ping
    Zhao, Yan
    Yan, Hui-Ping
    MEDICINE, 2020, 99 (03)
  • [26] Anti-GP210 antibody titer as a clinical parameter that predicts the long-term outcome of primary biliary cirrhosis under ursodeoxycholic acid treatment.
    Nakamura, M
    Shimizu-Yoshida, Y
    Takii, Y
    Komori, A
    Yokoyama, T
    Ueki, T
    Daikoku, M
    Yano, K
    Matsumoto, T
    Yatsuhashi, H
    Ito, M
    Ishibashi, H
    HEPATOLOGY, 2004, 40 (04) : 458A - 459A
  • [27] Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
    Shi, Han
    Wang, Qi
    Liu, Hui
    Xu, Bin
    Liu, Yanmin
    Zhao, Juan
    Sun, Lina
    Chen, Dexi
    Huang, Chunyang
    Jin, Ronghua
    OPEN LIFE SCIENCES, 2024, 19 (01):
  • [28] The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210
    Yang, F.
    Yang, Y.
    Wang, Q.
    Wang, Z.
    Miao, Q.
    Xiao, X.
    Wei, Y.
    Bian, Z.
    Sheng, L.
    Chen, X.
    Qiu, D.
    Fang, J.
    Tang, R.
    Gershwin, M. E.
    Ma, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 733 - 743
  • [29] Anti-mitochondrial antibodies in primary biliary cirrhosis
    Neuberger, J
    Bradwell, AR
    JOURNAL OF HEPATOLOGY, 2002, 37 (06) : 712 - 716
  • [30] Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know
    Cristoferi, Laura
    Gerussi, Alessio
    Invernizzi, Pietro
    LIVER INTERNATIONAL, 2021, 41 (03) : 432 - 435
12345